These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 34613404

  • 1. Development of a Molecular Assay for Detection and Quantification of the BRAF Variation in Residual Tissue From Thyroid Nodule Fine-Needle Aspiration Biopsy Specimens.
    Fu G, Chazen RS, MacMillan C, Witterick IJ.
    JAMA Netw Open; 2021 Oct 01; 4(10):e2127243. PubMed ID: 34613404
    [Abstract] [Full Text] [Related]

  • 2. Fine-needle Aspiration Washout Precipitation Specimens: An Acceptable Supplement to Genetic Mutation Detection of Thyroid Nodules.
    Cui Y, Huang X, Guo J, Zhang N, Liang J, Zhang Y, Liao Y, He D.
    Technol Cancer Res Treat; 2021 Oct 01; 20():15330338211057982. PubMed ID: 34806478
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens.
    Smith GD, Zhou L, Rowe LR, Jarboe EA, Collins BT, Bentz JS, Wittwer CT, Chadwick BE.
    Acta Cytol; 2011 Oct 01; 55(6):576-83. PubMed ID: 22156469
    [Abstract] [Full Text] [Related]

  • 5. BRAFV600E mutation test on fine-needle aspiration specimens of thyroid nodules: Clinical correlations for 4600 patients.
    Chen H, Song A, Wang Y, He Y, Tong J, Di J, Li C, Zhou Z, Cai X, Zhong D, Da J.
    Cancer Med; 2022 Jan 01; 11(1):40-49. PubMed ID: 34851044
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the Clinical Validity of Droplet Digital PCR to ARMS-PCR for BRAF V600E Mutation Detection in Thyroid Nodules.
    Li X, Du H, Luo J, Ding W, Lai B, He J, Xu S, Zhang Y.
    J Clin Lab Anal; 2020 Nov 01; 34(11):e23458. PubMed ID: 32671901
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic Value and Challenges of BRAF V600E Molecular Testing and Thyroid Fine-Needle Aspiration Cytology: A Retrospective Study from a Tertiary Institution in Southern Hunan Province, China.
    Lan Z, Yang F, Zhang J, Lan Y, Li H, He R.
    Acta Cytol; 2023 Nov 01; 67(6):629-638. PubMed ID: 37708867
    [Abstract] [Full Text] [Related]

  • 8. Detection of BRAF V600E mutation in fine-needle aspiration fluid of papillary thyroid carcinoma by droplet digital PCR.
    Xu X, Ma X, Zhang X, Cao G, Tang Y, Deng X, Kang Z, Li M, Guan M.
    Clin Chim Acta; 2019 Apr 01; 491():91-96. PubMed ID: 30682328
    [Abstract] [Full Text] [Related]

  • 9. Facilitation of Definitive Cancer Diagnosis With Quantitative Molecular Assays of BRAF V600E and TERT Promoter Variants in Patients With Thyroid Nodules.
    Fu G, Chazen RS, Monteiro E, Vescan A, Freeman JL, Witterick IJ, MacMillan C.
    JAMA Netw Open; 2023 Jul 03; 6(7):e2323500. PubMed ID: 37505499
    [Abstract] [Full Text] [Related]

  • 10. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.
    Chung KW, Yang SK, Lee GK, Kim EY, Kwon S, Lee SH, Park DJ, Lee HS, Cho BY, Lee ES, Kim SW.
    Clin Endocrinol (Oxf); 2006 Nov 03; 65(5):660-6. PubMed ID: 17054470
    [Abstract] [Full Text] [Related]

  • 11. The Combined Use of Fine-Needle Aspiration (FNA) and BRAF V600E Gene Testing: Can it Increase the Definitive Diagnosis Rate of Nodules Categorized as Bethesda III for Papillary Thyroid Carcinoma?
    Lei L, Hong Qing S, Wei L, Ma Mo Yang F, Xiao Xiang Y.
    Am Surg; 2024 Dec 03; 90(12):3209-3215. PubMed ID: 39047144
    [Abstract] [Full Text] [Related]

  • 12. Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.
    Lee ST, Kim SW, Ki CS, Jang JH, Shin JH, Oh YL, Kim JW, Chung JH.
    J Clin Endocrinol Metab; 2012 Jul 03; 97(7):2299-306. PubMed ID: 22500044
    [Abstract] [Full Text] [Related]

  • 13. BRAF mutation analysis by ARMS-PCR refines thyroid nodule management.
    Li X, Li E, Du J, Wang J, Zheng B.
    Clin Endocrinol (Oxf); 2019 Dec 03; 91(6):834-841. PubMed ID: 31441082
    [Abstract] [Full Text] [Related]

  • 14. BRAF V600E mutation analysis of thyroid nodules needle aspirates in relation to their ultrasongraphic classification: a potential guide for selection of samples for molecular analysis.
    Nam SY, Han BK, Ko EY, Kang SS, Hahn SY, Hwang JY, Nam MY, Kim JW, Chung JH, Oh YL, Shin JH.
    Thyroid; 2010 Mar 03; 20(3):273-9. PubMed ID: 20187782
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the Anyplex BRAF V600E real-time detection assay using dual-priming oligonucleotide technology in fine-needle aspirates of thyroid nodules.
    Choi R, Park KS, Kim JW, Ki CS.
    Ann Lab Med; 2015 Nov 03; 35(6):624-9. PubMed ID: 26354351
    [Abstract] [Full Text] [Related]

  • 16. Analysis of BRAF(V600E) mutation and DNA methylation improves the diagnostics of thyroid fine needle aspiration biopsies.
    Zhang B, Liu S, Zhang Z, Wei J, Qu Y, Wu K, Yang Q, Hou P, Shi B.
    Diagn Pathol; 2014 Mar 03; 9():45. PubMed ID: 24588959
    [Abstract] [Full Text] [Related]

  • 17. [Clinical role of BRAF V600E mutation testing in thyroid nodules].
    Wan H, Zhang B, Wang Y, Xiao T, Guo H, Liu W, Yan D, Xu Z, Tang P.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jun 03; 49(6):468-72. PubMed ID: 25241863
    [Abstract] [Full Text] [Related]

  • 18. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.
    Marchetti I, Lessi F, Mazzanti CM, Bertacca G, Elisei R, Coscio GD, Pinchera A, Bevilacqua G.
    Thyroid; 2009 Aug 03; 19(8):837-42. PubMed ID: 19534623
    [Abstract] [Full Text] [Related]

  • 19. Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma.
    Zimmermann AK, Camenisch U, Rechsteiner MP, Bode-Lesniewska B, Rössle M.
    Cancer Cytopathol; 2014 Jan 03; 122(1):48-58. PubMed ID: 24039206
    [Abstract] [Full Text] [Related]

  • 20. Discriminating Interpatient Variabilities of RAS Gene Variants for Precision Detection of Thyroid Cancer.
    Fu G, Chazen RS, MacMillan C, Witterick IJ.
    JAMA Netw Open; 2024 May 01; 7(5):e2411919. PubMed ID: 38758552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.